| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 98.6621 | 75 |
| GSM780708 | Untreated after 4 days (C2_1) | 92.1506 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 100.35 | 75 |
| GSM780719 | Untreated after 4 days (C1_2) | 84.7069 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 87.006 | 73 |
| GSM780721 | Untreated after 4 days (C3_2) | 92.1799 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 91.0786 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 86.5899 | 73 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 83.894 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 98.9045 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 86.6391 | 73 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 92.3646 | 74 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 98.1495 | 75 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 91.2075 | 74 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 91.2553 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 81.5845 | 72 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 92.0137 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 80.2296 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 86.6081 | 73 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 102.479 | 76 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 98.9277 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 84.978 | 73 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 90.6235 | 74 |